Trimodal for Gynecologic Cancers

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Saint Louis University, Saint Louis, MOGynecologic Cancers+6 MoreUnimodal - Other
Eligibility
18 - 90
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether a pre-surgery program can improve outcomes for gynecologic cancer patients.

Eligible Conditions
  • Gynecologic Cancers
  • Ovarian Cancer
  • Surgery
  • Endometrial Cancer
  • Cervical Cancer
  • Treatment Compliance
  • Quality of Life

Treatment Effectiveness

Study Objectives

3 Primary · 5 Secondary · Reporting Duration: During the 8 weeks after surgery (12 week approximate total study period)

Week 12
Treatment Completion
Week 12
Patient Satisfaction
Week 12
Complication Rates
Quality of Life FACT-G Assessment
Week 12
Readmission Rates
Week 12
Grip Strength
Six Minute Walk Test
Timed Up and Go

Trial Safety

Trial Design

2 Treatment Groups

Trimodal
1 of 2
Unimodal
1 of 2

Active Control

164 Total Participants · 2 Treatment Groups

Primary Treatment: Trimodal · No Placebo Group · N/A

Trimodal
Other
ActiveComparator Group · 1 Intervention: Trimodal · Intervention Types: Other
Unimodal
Other
ActiveComparator Group · 1 Intervention: Unimodal · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: during the 8 weeks after surgery (12 week approximate total study period)

Who is running the clinical trial?

St. Louis UniversityLead Sponsor
187 Previous Clinical Trials
37,988 Total Patients Enrolled
1 Trials studying Gynecologic Cancers
120 Patients Enrolled for Gynecologic Cancers
Shannon Grabosch, MDPrincipal Investigator - St. Louis University
SSM St. Mary's Health Center, St. Louis University Hospital, St. Luke's Hospital
1 Previous Clinical Trials
120 Total Patients Enrolled
1 Trials studying Gynecologic Cancers
120 Patients Enrolled for Gynecologic Cancers

Eligibility Criteria

Age 18 - 90 · Female Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is this clinical trial open to minors?

"This study stipulates that participants must be aged 18 or older, but no more than 90 years old." - Anonymous Online Contributor

Unverified Answer

How many participants is the maximum capacity for this medical experiment?

"Affirmative. According to information available on clinicaltrials.gov, recruitment for this medical trial is underway; it was initially posted on July 21st 2020 and most recently adjusted on April 14th 2022. A total of 164 patients are required across 1 location in order to complete the study." - Anonymous Online Contributor

Unverified Answer

Does my background qualify me to participate in this experimental research?

"In order to be eligible for the trial, individuals must meet two criteria: they must maintain treatment compliance and their age should fall between 18 - 90. Thus far, 164 people have been accepted into this experimental program." - Anonymous Online Contributor

Unverified Answer

Are registrants currently being accepted for this clinical investigation?

"Affirmative. The clinicaltrials.gov database confirms the ongoing recruitment of 164 patients at a single site for this medical trial, which was originally listed on July 21st 2020 and updated most recently on April 14th 2022." - Anonymous Online Contributor

Unverified Answer

What major goals is this research endeavor attempting to accomplish?

"The focal point of this study over the 12 week period is to quantify Grip Strength, while other metrics such as Need for Postoperative Readmission and Rate of Program Completion are also being assessed. In addition, Quality of Life will be monitored using the FACT-G (Functional Assessment of Cancer Therapy-General), which consists of 28 questions that generate a score between 0 and 112 with higher scores correlating to better quality life." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.